Calpastatin in rat myoblasts: Transient diminution and decreased phosphorylation depend on myogenin-directed myoblast differentiation

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 1, 2007, Pages 253-261

  Barnoy, Sivia ^a   Kosower, Nechama S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Calpain; Calpastatin; Caspase; Myoblast fusion; Myogenin

Indexed keywords

CALPASTATIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; MYOGENIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL LINE; MYOBLAST; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CALCIUM-BINDING PROTEINS; CASPASE 1; CELL DIFFERENTIATION; CELL FUSION; CELL LINE; ENZYME ACTIVATION; MYOBLASTS; MYOGENIN; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS;

EID: 33749591567     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.08.008     Document Type: Article

References (38)

1. Adachi Y., Ishida-Takahashi A., Takahashi C., et al. Phosphorylation and subcellular distribution of calpastatin in human hematopoietic cells. J. Biol. Chem. 266 (1991) 3968-3972
2. Andres V., and Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132 (1996) 657-666
3. Averna M., de Tullio R., Passalacqua M., et al. Changes in intracellular calpastatin localization are mediated by reversible phosphorylation. Biochem. J. 354 (2001) 25-30
4. Balcerzak D., Cottin P., Poussard S., et al. Calpastatin-modulation of m-calpain activity is required for myoblast fusion. Eur. J. Cell Biol. 75 (1998) 247-253
5. Balcerzak D., Poussard S., Brustis J.J., et al. An antisense oligodeoxyribonucleotide to m-calpain mRNA inhibits myoblast fusion. J. Cell Sci. 108 (1995) 2077-2082
6. Barnoy S., Glaser T., and Kosower N.S. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion. Biochem. Biophys. Res. Commun. 220 (1996) 933-938
7. Barnoy S., Glaser T., and Kosower N.S. Calpain and calpastatin in myoblast differentiation and fusion: Effects of inhibitors. Biochim. Biophys. Acta 1358 (1997) 181-188
8. Barnoy S., Glaser T., and Kosower N.S. The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochim. Biophys. Acta 1402 (1998) 52-60
9. Barnoy S., and Kosower N.S. Caspase-1-induced calpastatin degradation in myoblast differentiation and fusion: Cross-talk between the caspase and calpain systems. FEBS Lett. 546 (2003) 213-217
10. Barnoy S., Maki M., and Kosower N.S. Overexpression of calpastatin inhibits L8 myoblast fusion. Biochem. Biophys. Res. Commun. 332 (2005) 697-701
11. Barnoy S., Supino-Rosin L., and Kosower N.S. Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability. Biochem. J. 351 (2000) 413-420
12. 2+-dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts. J. Cell. Biochem. 74 (1999) 522-531
13. Bennett A.M., and Tonks N.K. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278 (1997) 1288-1291
14. Blais A., Tsikitis M., Acosta-Alvear D., et al. An initial blueprint for myogenic differentiation. Genes Dev. 19 (2005) 553-569
15. Brennan T.J., Edmondson D.G., Li L., et al. Transforming growth factor β represses the actions of myogenin through a mechanism independent of DNA binding. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3822-3826
16. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15 (1993) 532-537
17. Clemente C.F.M.Z., Corat M.A.F., Saad S.T.O., et al. Differentiation of C2C12 myoblasts is critically regulated by FAK signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) R862-R870
18. Datta B., Datta R., Majumdar A., et al. The stability of eukaryotic initiation factor 2-associated glycoprotein, p67, increases during skeletal muscle differentiation and that inhibits the phosphorylation of extracellular signal-regulated kinases 1 and 2. Exp. Cell Res. 303 (2005) 174-182
19. Dedieu S., Dourdin N., Dargelos E., et al. Calpain and myogenesis: Development of a convenient cell culture model. Biol. Cell 94 (2002) 65-76
20. Filvaroff E.H., Ebner R., and Derynck R. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-β receptor. Development 120 (1994) 1085-1095
21. Fulton A.B., Prives J., Farmer S.R., et al. Developmental reorganization of the skeletal framework and its surface lamina in fusing muscle cells. J. Cell Biol. 91 (1981) 103-112
22. Goll D.E., Thompson V.F., Li H., et al. The calpain system. Physiol. Rev. 83 (2003) 731-801
23. Hasty P., Bradley A., Morris J.H., et al. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364 (1993) 501-506
24. Heino J., and Massague J. Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor. J. Biol. Chem. 265 (1990) 10181-10184
25. Huang J., and Forsberg N.E. Role of calpain in skeletal-muscle protein degradation. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 12100-12105
26. Liang Y.-C., Yeh J.-Y., Forsberg N.E., et al. Involvement of μ- and m-calpains and protein kinase C isoforms in L8 myoblast differentiation. Int. J. Biochem. Cell Biol. 38 (2006) 662-670
27. Myer A., Olson E.N., and Klein W.H. MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. Dev. Biol. 229 (2001) 340-350
28. Nabeshima Y., Hanaoka K., Hayasaka M., et al. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364 (1993) 532-535
29. Rawls A., and Olson E.N. MyoD meets its maker. Cell 89 (1997) 5-8
30. Sabourin L.A., and Rudunicki M.A. The molecular regulation of myogenesis. Clin. Genet. 57 (2000) 16-25
31. Salamino F., de Tullio R., Michetti M., et al. Modulation of calpastatin specificity in rat tissues by reversible phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 199 (1994) 1326-1332
32. Schwarz-Benmeir N., Glaser T., Barnoy S., et al. Calpastatin in erythrocytes of young and old individuals. Biochem. J. 304 (1994) 365-370
33. Temm-Grove C.J., Wert D., Thompson V.F., et al. Microinjection of calpastatin inhibits fusion in myoblasts. Exp. Cell Res. 247 (1999) 293-303
34. Tharin S., Hamel P.A., Conway E.M., et al. Regulation of calcium binding proteins calreticulin and calsequestrin during differentiation in the myogenic cell line L6. J. Cell. Physiol. 166 (1996) 547-560
35. Weston A.D., Sampaio A.V., Ridgeway A.G., et al. Inhibition of p38 MAPK signaling promotes late stages of myogenesis. J. Cell Sci. 116 (2003) 2885-2893
36. Yaffe D. Cellular aspects of muscle differentiation in vitro. Curr. Top. Dev. Biol. 4 (1969) 37-77
37. Yaffe D., and Saxel O.A. Myogenic cell line with altered serum requirements for differentiation. Differentiation 7 (1977) 159-166
38. Zuk, D. (1994). Regulatory genes involved in myogenesis. PhD Thesis, Weizmann Institute of Science, Rehovot, Israel.